Inventor
BRUECKNER REINHARD
DE20 patents
⚠️ This page may combine multiple inventors who share the name “BRUECKNER REINHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SOLVAY PHARM GMBH
12 patentsUS7241770B2Jul 10, 2007
Hydronopol derivatives as agonists on human ORL1 receptors
SOLVAY PHARM GMBH23 citations88
US7368582B2May 6, 2008
Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
SOLVAY PHARM GMBH11 citations81
US6602880B2Aug 5, 2003
3-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia
SOLVAY PHARM GMBH7 citations73
US7767692B2Aug 3, 2010
1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds
SOLVAY PHARM GMBH7 citations72
US6407106B1Jun 18, 2002
N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity
SOLVAY PHARM GMBH7 citations72
US6001833ADec 14, 1999
Urea derivatives
SOLVAY PHARM GMBH10 citations72
US6770649B2Aug 3, 2004
1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
SOLVAY PHARM GMBH2 citations61
US5972948AOct 26, 1999
Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
SOLVAY PHARM GMBH2 citations60
US7714150B2May 11, 2010
Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
SOLVAY PHARM GMBH0 citations49
US7534903B2May 19, 2009
Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease states
SOLVAY PHARM GMBH0 citations49
US6040303AMar 21, 2000
7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
SOLVAY PHARM GMBH0 citations40
US7592344B2Sep 22, 2009
NK1 and NK2-antagonists and compositions and methods of using the same
SOLVAY PHARM GMBH0 citations39
KALI CHEMIE PHARMA GMBH
6 patentsUS5712283AJan 27, 1998
Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
KALI CHEMIE PHARMA GMBH10 citations71
US5576327ANov 19, 1996
Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds
KALI CHEMIE PHARMA GMBH8 citations71
US5547967AAug 20, 1996
(Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them
KALI CHEMIE PHARMA GMBH13 citations71
US5679699AOct 21, 1997
(Phenylalkylaminoalkyloxy) -heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them
KALI CHEMIE PHARMA GMBH3 citations60
US5532251AJul 2, 1996
Method of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazabicyclo[3.3.1]nonane compounds
KALI CHEMIE PHARMA GMBH6 citations60
US5635511AJun 3, 1997
Treatment of heart rhythm disorders by administration of 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds.
KALI CHEMIE PHARMA GMBH1 citations50